Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

From the margins to mainstream: How providers of autologous 'stem cell treatments' legitimise their practice in Australia.

MacGregor C, Petersen A, Munsie M.

Health (London). 2019 May 13:1363459319846927. doi: 10.1177/1363459319846927. [Epub ahead of print]

PMID:
31081381
2.

Citizens' use of digital media to connect with health care: Socio-ethical and regulatory implications.

Petersen A, Tanner C, Munsie M.

Health (London). 2019 May 2:1363459319847505. doi: 10.1177/1363459319847505. [Epub ahead of print]

PMID:
31045440
3.

The politics of evidence in online illness narratives: An analysis of crowdfunding for purported stem cell treatments.

Tanner C, Munsie M, Sipp D, Turner L, Wheatland C.

Health (London). 2019 Feb 19:1363459319829194. doi: 10.1177/1363459319829194. [Epub ahead of print]

PMID:
30782021
4.

Debate ethics of embryo models from stem cells.

Rivron N, Pera M, Rossant J, Martinez Arias A, Zernicka-Goetz M, Fu J, van den Brink S, Bredenoord A, Dondorp W, de Wert G, Hyun I, Munsie M, Isasi R.

Nature. 2018 Dec;564(7735):183-185. doi: 10.1038/d41586-018-07663-9. No abstract available.

PMID:
30542177
5.

A roundtable on responsible innovation with autologous stem cells in Australia, Japan and Singapore.

Lysaght T, Munsie M, Castricum A, Hui JHP, Okada K, Sato Y, Sawa Y, Stewart C, Tan LK, Tan LHY, Sugii S.

Cytotherapy. 2018 Sep;20(9):1103-1109. doi: 10.1016/j.jcyt.2018.06.004. Epub 2018 Aug 19.

PMID:
30131270
6.

The current state of stem cell therapy for ocular disease.

Bobba S, Di Girolamo N, Munsie M, Chen F, Pébay A, Harkin D, Hewitt AW, O'Connor M, McLenachan S, Shadforth AMA, Watson SL.

Exp Eye Res. 2018 Dec;177:65-75. doi: 10.1016/j.exer.2018.07.019. Epub 2018 Jul 17. Review.

PMID:
30029023
7.

Emerging stem cell ethics.

Sipp D, Munsie M, Sugarman J.

Science. 2018 Jun 22;360(6395):1275. doi: 10.1126/science.aau4720. No abstract available.

PMID:
29930112
8.

Ethical issues in genetic modification and why application matters.

Munsie M, Gyngell C.

Curr Opin Genet Dev. 2018 Oct;52:7-12. doi: 10.1016/j.gde.2018.05.002. Epub 2018 May 23. Review.

PMID:
29800628
9.

Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan.

Munsie M, Lysaght T, Hendl T, Tan HL, Kerridge I, Stewart C.

Regen Med. 2017 Nov 10. doi: 10.2217/rme-2017-0070. [Epub ahead of print]

PMID:
29125016
10.

'No one here's helping me, what do you do?': addressing patient need for support and advice about stem cell treatments.

Tanner C, Petersen A, Munsie M.

Regen Med. 2017 Oct;12(7):791-801. doi: 10.2217/rme-2017-0056. Epub 2017 Nov 8.

PMID:
29115901
11.

The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.

Morrison M, Bell J, George C, Harmon S, Munsie M, Kaye J.

Regen Med. 2017 Sep;12(6):693-703. doi: 10.2217/rme-2017-0068. Epub 2017 Oct 4.

12.

Regulating the stem cell industry: needs and responsibilities.

Lee TL, Lysaght T, Lipworth W, Hendl T, Kerridge I, Munsie M, Stewart C.

Bull World Health Organ. 2017 Sep 1;95(9):663-664. doi: 10.2471/BLT.16.189977. Epub 2017 Jul 1. No abstract available.

13.

Marketing of unproven stem cell-based interventions: A call to action.

Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaag0426. doi: 10.1126/scitranslmed.aag0426. Review.

14.

The deadly business of an unregulated global stem cell industry.

Lysaght T, Lipworth W, Hendl T, Kerridge I, Lee TL, Munsie M, Waldby C, Stewart C.

J Med Ethics. 2017 Nov;43(11):744-746. doi: 10.1136/medethics-2016-104046. Epub 2017 Mar 29.

PMID:
28356490
15.

Ethical issues in human organoid and gastruloid research.

Munsie M, Hyun I, Sugarman J.

Development. 2017 Mar 15;144(6):942-945. doi: 10.1242/dev.140111. Review.

16.

Participant understanding and recall of informed consent for induced pluripotent stem cell biobanking.

McCaughey T, Chen CY, De Smit E, Rees G, Fenwick E, Kearns LS, Mackey DA, MacGregor C, Munsie M, Cook AL, Pébay A, Hewitt AW.

Cell Tissue Bank. 2016 Sep;17(3):449-56. doi: 10.1007/s10561-016-9563-8. Epub 2016 Jun 14.

PMID:
27299783
17.

Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines.

Daley GQ, Hyun I, Apperley JF, Barker RA, Benvenisty N, Bredenoord AL, Breuer CK, Caulfield T, Cedars MI, Frey-Vasconcells J, Heslop HE, Jin Y, Lee RT, McCabe C, Munsie M, Murry CE, Piantadosi S, Rao M, Rooke HM, Sipp D, Studer L, Sugarman J, Takahashi M, Zimmerman M, Kimmelman J.

Stem Cell Reports. 2016 Jun 14;6(6):787-797. doi: 10.1016/j.stemcr.2016.05.001. Epub 2016 May 12.

18.

An Interactive Multimedia Approach to Improving Informed Consent for Induced Pluripotent Stem Cell Research.

McCaughey T, Liang HH, Chen C, Fenwick E, Rees G, Wong RC, Vickers JC, Summers MJ, MacGregor C, Craig JE, Munsie M, Pébay A, Hewitt AW.

Cell Stem Cell. 2016 Mar 3;18(3):307-8. doi: 10.1016/j.stem.2016.02.006. No abstract available.

19.

What if stem cells turn into embryos in a dish?

Pera MF, de Wert G, Dondorp W, Lovell-Badge R, Mummery CL, Munsie M, Tam PP.

Nat Methods. 2015 Oct;12(10):917-9. doi: 10.1038/nmeth.3586.

PMID:
26418764
20.

Regulatory loophole enables unproven autologous cell therapies to thrive in Australia.

Munsie M, Pera M.

Stem Cells Dev. 2014 Dec;23 Suppl 1:34-8. doi: 10.1089/scd.2014.0332.

PMID:
25457959
21.

Between hope and evidence: how community advisors demarcate the boundary between legitimate and illegitimate stem cell treatments.

Petersen A, Tanner C, Munsie M.

Health (London). 2015 Mar;19(2):188-206. doi: 10.1177/1363459314555240. Epub 2014 Nov 2.

PMID:
25367895
22.

Managing the potential and pitfalls during clinical translation of emerging stem cell therapies.

Main H, Munsie M, O'Connor MD.

Clin Transl Med. 2014 May 9;3:10. doi: 10.1186/2001-1326-3-10. eCollection 2014. Review.

23.

A question of ethics: selling autologous stem cell therapies flaunts professional standards.

Munsie M, Hyun I.

Stem Cell Res. 2014 Nov;13(3 Pt B):647-53. doi: 10.1016/j.scr.2014.04.014. Epub 2014 Apr 29. Review.

24.

Therapeutic journeys: the hopeful travails of stem cell tourists.

Petersen A, Seear K, Munsie M.

Sociol Health Illn. 2014 Jun;36(5):670-85. doi: 10.1111/1467-9566.12092. Epub 2013 Nov 25.

PMID:
24266861
25.

Tempering hope with realism: induced pluripotent stem cells in regenerative medicine.

Fung RK, Kerridge IH, Skene LL, Munsie MJ.

Med J Aust. 2012 Jun 4;196(10):622-5. No abstract available.

PMID:
22676869
26.

Isolation and production of cells suitable for human therapy: challenges ahead.

Ahrlund-Richter L, De Luca M, Marshak DR, Munsie M, Veiga A, Rao M.

Cell Stem Cell. 2009 Jan 9;4(1):20-6. doi: 10.1016/j.stem.2008.11.012. Epub 2008 Dec 8.

27.

New ISSCR guidelines underscore major principles for responsible translational stem cell research.

Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ.

Cell Stem Cell. 2008 Dec 4;3(6):607-9. doi: 10.1016/j.stem.2008.11.009. Review.

28.

Transgenic systems in nuclear reprogramming.

Munsie M, Mountford P, Nichols J.

Methods Mol Biol. 2006;325:115-28.

PMID:
16761723
29.

Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiation.

Lang RJ, Haynes JM, Kelly J, Johnson J, Greenhalgh J, O'brien C, Mulholland EM, Baker L, Munsie M, Pouton CW.

Eur J Neurosci. 2004 Dec;20(12):3209-21.

PMID:
15610154
30.

Transgenic strategy for demonstrating nuclear reprogramming in the mouse.

Munsie M, O'brien C, Mountford P.

Cloning Stem Cells. 2002;4(2):121-30.

PMID:
12180428
31.

Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei.

Munsie MJ, Michalska AE, O'Brien CM, Trounson AO, Pera MF, Mountford PS.

Curr Biol. 2000 Aug 24;10(16):989-92.

32.

Novel method for demonstrating nuclear contribution in mouse nuclear transfer.

Munsie M, Peura T, Michalska A, Trounson A, Mountford P.

Reprod Fertil Dev. 1998;10(7-8):633-7.

PMID:
10612469
33.

Expression of stem cell factor in the postnatal rat testis.

Munsie M, Schlatt S, deKretser DM, Loveland KL.

Mol Reprod Dev. 1997 May;47(1):19-25.

PMID:
9110310

Supplemental Content

Loading ...
Support Center